Here are four things to know:
1. The firm presently owns nearly 1.3 million Orthofix International shares for a $52.5 million total value.
2. Orthofix International shares comprise nearly 1.27 percent of Segall Bryant Hamill’s portfolio.
3. For the quarter, Orthofix shares had $0.28 earnings per share, surpassing the analyst consensus estimate by $0.07.
4. The company had revenue reaching $104.6 million for the quarter.
More articles on devices:
ArthroMeda raises nearly $2M for hip replacement sensors — 5 takeaways
Mesoblast’s Mesenchymal Precursor Cells receives key patent — 5 takeaways
DJO Global 2015 net sales hit $308M; Net loss hits $349.9M: 8 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
